Barclays »

Verve Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.7M 195k 13.93
2023-09-30 $1.9M 144k 13.26
2023-06-30 $2.3M 121k 18.75
2023-03-31 $1.6M 109k 14.42
2022-12-31 $3.9M 202k 19.35
2022-09-30 $3.9M 114k 34.35
2022-06-30 $73k 4.9k 15.11
2022-03-31 $571k 25k 22.84